WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,56 $
arrow_upward
+0,48%(+0,060) 1D
16. okt., 16:00:00 GMT -4 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za WXXWY …
Odpri
12,29 $
Visoka
12,56 $
Nizka
12,20 $
Tržna kapitalizacija
198,43 mrd.
Povprečni promet
61,89 tis.
Promet
110,85 tis.
52-tedenski najvišji tečaj
14,80 $
52-tedenski najnižji tečaj
7,30 $
Beta
0,01
Št. izdanih delnic
2,06 mrd.
Št. zaposlenih
15 tis.
Odpri
12,29 $
Visoka
12,56 $
Nizka
12,20 $
Tržna kapitalizacija
198,43 mrd.
Povprečni promet
61,89 tis.
Promet
110,85 tis.
52-tedenski najvišji tečaj
14,80 $
52-tedenski najnižji tečaj
7,30 $
Beta
0,01
Št. izdanih delnic
2,06 mrd.
Št. zaposlenih
15 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Delo.si
·
pred 13 urami
Borza deluje mirno. Pod površjem ni tako
Seeking Alpha
·
pred 57 minutami
SH: A Tactical Hedge, But Not Yet A Short Call (NYSEARCA:SH)
Foreign Policy Journal
·
pred 1 uro
Super Micro Computer (NASDAQ: SMCI) Signals Were Visible Before Its Stock 45% Rally
Yahoo Finance
·
pred 11 urami
Michael Burry Warns of a Stock Market ‘Supervolcano’
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Vizitka: Wuxi Biologics Cayman ADR
Generalni direktorZhisheng Chen
Št. zaposlenih14,7 tis.
Ustanovljeno2010
Sedež-
Sektor-
Spletno mestowuxibiologics.com